Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A phase 2 randomized study of SHAPE Gel (SHP-141) in patients with early-stage cutaneous T-cell lymphoma: Interim results. Duvic, M., Kim, Y. H., LeBoeuf, N. R., Porcu, P., Hastings, J., Bassuner, J., Sowerby, L., Posligua-Alban, A., Guitart, J. AMER SOC CLINICAL ONCOLOGY. 2016
View details for DOI 10.1200/JCO.2016.34.15_suppl.7562
View details for Web of Science ID 000404711505075